Good morning :)
Switch to

Cipla Ltd

CIPLA
Health CarePharmaceuticals
LargecapWith a market cap of ₹36,438 cr, stock is ranked 72
Low RiskStock is 1.25x as volatile as Nifty
463.3011.25 (+2.48%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Current price is more than the intrinsic value

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Stock has been generating better return on equity than bank FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Stock doesn't offer attractive dividend returns

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

Good time to consider, as stock is not in overbought zone

No Red Flags
ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list, with high pledged promoter holding or high default probability should be handled with caution

Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low

Health CarePharmaceuticals
LargecapWith a market cap of ₹36,438 cr, stock is ranked 72
Low RiskStock is 1.25x as volatile as Nifty

Key Ratios

PE RatioPE Ratio
Close price divided by the earnings per share, excluding extraordinary items
23.87
PB RatioPB Ratio
Close price divided by the book value per share at the end of the most recent financial year
2.42
Dividend YieldDiv. Yield
Dividend Per Share for the most recent financial year divided by the close price
0.66%
Sector PESector PE
Market cap weighted-average PE ratio of the sector the stock belongs to
26.25
Sector PBSector PB
Market cap weighted-average PB ratio of the sector the stock belongs to
2.89
Sector Div YldSctr Div Yld
Market cap weighted-average dividend yield of the sector the stock belongs to
0.81%

Forecast & RatingsDetailed Forecast 

51%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

About & PeersCompare with peers 

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

PE Ratio
24.46
1Y Return
-29.07%
Buy Reco %
50.00%
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key ratios, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201620172018201913.7914.6315.2116.361.351.001.411.52
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates
Announced OnSep 19, 2019

Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Allotment of ESOP/ESPS
Announced OnSep 16, 2019

Cipla Limited has informed the Exchange regarding allotment of 122883 Equity Shares under ESOP

Cash Dividend
Ex. DateAug 13, 2018

Final • Div/Share: ₹ 3

See all events

Tickertape provides data, information & content for Indian stocks, ETFs & indices.

Data powered byPrices shown are delayed by 15 minutes© Tickertape 2019